Artara Therapeutics
$23.619876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$23.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.40 (+6.48%) Today
+$0.61 (+2.65%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell TARA and other stocks, options, ETFs, and crypto commission-free!
About TARA
ArTara Therapeutics, Inc. Common Stock, also called Artara Therapeutics, is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Read More Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY.
Employees
12
Headquarters
New York, New York
Founded
2017
Market Cap
127.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
8.72K
High Today
$23.35
Low Today
$21.25
Open Price
$21.51
Volume
4.29K
52 Week High
$42.49
52 Week Low
$8.80
TARA Earnings
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Available Mar 20, Pre-Market